临床案例 / 真实世界数据

吾谷灵™五谷虫临床案例汇总与分析（卵巢癌伴淋巴结转移）

吾谷灵™临床数据中心发布日期 2024约 8 分钟阅读

关键数据一览

1.2cm

盆内最大病灶

缩小 52%

2.5cm → 1.2cm

正常

肿瘤标志物

全部恢复

临床症状改善

患者基本信息与治疗背景

刘XX，女，吉林省长春市。诊断高级别浆液性乳头状腺癌，伴网膜、双侧卵巢浸润，左侧髂外淋巴结转移，盆腔积液。术后盆内肠旁多发实性肿块（最大2.5cm）。

治疗过程与疗效

治疗时间：2015年6月至11月（5个月），单独服用吾谷灵™五谷虫，未联合其他治疗。

影像学变化：服药后最大病灶缩小至1.2cm，其他病灶大部分消失或缩小。肿瘤标志物全部恢复正常。临床症状：精神状态、食欲、身体机能显著改善。

机制分析

五谷虫提取物（ME）通过靶向 HSP90AB1 抑制卵巢癌细胞增殖迁移；上调促凋亡蛋白、下调抗凋亡蛋白；安全性良好，或成为化疗不耐受患者的替代/辅助方案。

个案仅供参考，不构成医疗建议。

医学报告与数据

重要声明：本页面为吾谷灵™五谷虫真实世界辅助调理个案整理，仅供学术交流参考，不构成医疗建议，不能替代手术、放疗、化疗等标准抗肿瘤治疗。个案结果因人而异，具体用药请遵医嘱。

Clinical Cases / Real-world Data

Vogreen Medicinal Housefly Larvae Clinical Case Summary (Ovarian Cancer with Lymph Node Metastasis)

Vogreen Clinical Data CenterReleased 2024About 8 min read

Key Data Overview

1.2cm

Largest Pelvic Lesion

Shrunk 52%

2.5cm → 1.2cm

Normal

Tumor Markers

All normalized

Clinical symptoms improved

Case Summary

A patient with advanced serous ovarian cancer and lymph node metastasis took Vogreen Medicinal Housefly Larvae monotherapy for 5 months (June-November 2015). The largest pelvic lesion shrank from 2.5cm to 1.2cm, most other lesions disappeared, and all tumor markers normalized with improved clinical symptoms. Vogreen extract inhibits HSP90AB1 and promotes apoptosis. For reference only, not medical advice.

Key Data & Reports

Please refer to the medical reports and data charts below for detailed examination results and imaging records.

Medical Reports & Data

Ovarian cancer imaging and test reports — pelvic lesion comparison

Tumor marker test report — all normalized

Disclaimer: This page documents a real-world adjuvant care case of Vogreen Medicinal Housefly Larvae for academic exchange only. It does not constitute medical advice and cannot replace standard anti-tumor treatments such as surgery, radiotherapy or chemotherapy. Individual results vary. Please follow your physician's guidance.